share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Director Drutz David

Altimmune | 4: Statement of changes in beneficial ownership of securities-Director Drutz David

Altimmune | 4：持股變動聲明-董事 Drutz David
美股SEC公告 ·  08/21 06:08
牛牛AI助理已提取核心訊息
On August 19, 2024, Dr. David Drutz, associated with Altimmune, Inc. [ALT], engaged in multiple transactions involving the company's common stock. Dr. Drutz acquired a total of 41,750 shares through the exercise of derivative securities at prices ranging from $2.50 to $2.60. Subsequently, Dr. Drutz sold a total of 16,011 shares on the open market at prices between $6.88 and $6.93, resulting in a total market value of $110,547.03 for the disposed shares. After these transactions, Dr. Drutz's beneficial ownership in Altimmune stands at 55,524 shares.
On August 19, 2024, Dr. David Drutz, associated with Altimmune, Inc. [ALT], engaged in multiple transactions involving the company's common stock. Dr. Drutz acquired a total of 41,750 shares through the exercise of derivative securities at prices ranging from $2.50 to $2.60. Subsequently, Dr. Drutz sold a total of 16,011 shares on the open market at prices between $6.88 and $6.93, resulting in a total market value of $110,547.03 for the disposed shares. After these transactions, Dr. Drutz's beneficial ownership in Altimmune stands at 55,524 shares.
2024年8月19日，與altimmune有關聯的David Drutz醫生[ALT]進行了多項涉及該公司普通股的交易。Drutz醫生以2.50至2.60美元的價格通過衍生證券行使獲得了41750股。隨後，Drutz醫生以6.88至6.93美元的價格在公開市場上出售了總計16011股，該股票的總市值爲110,547.03美元。這些交易後，Drutz醫生在altimmune的受益持股數爲55,524股。
2024年8月19日，與altimmune有關聯的David Drutz醫生[ALT]進行了多項涉及該公司普通股的交易。Drutz醫生以2.50至2.60美元的價格通過衍生證券行使獲得了41750股。隨後，Drutz醫生以6.88至6.93美元的價格在公開市場上出售了總計16011股，該股票的總市值爲110,547.03美元。這些交易後，Drutz醫生在altimmune的受益持股數爲55,524股。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。